Transgenic studies demonstrate that EMILIN-1 deficiency leads to excessive tumor-associated lymphangiogenesis, accelerated gastric cancer cell dissemination via LVs, and more aggressive lesion development. Here, EMILIN1 is linked to neoplasm.